Saltar al contenido

ELI Lilly & Co (LLY) stock: revenue, earnings & dividend

ELI Lilly & Co (LLY, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener LLY · NYSE Pharma & Biotech US-IN

Key figures

Fiscal year
2025
Revenue
65.2 bn $
Revenue growth
44.7 %
Revenue growth 5y (p.a.)
21.6 %
Net income
20.6 bn $
Net margin
31.7 %
Operating margin
–
Earnings per share (diluted)
22.95 $
Dividend per share
6.23 $
Payout ratio
27.2 %
Consecutive dividend years
10 years
Consecutive dividend raises
9 years
Dividend growth 5y (p.a.)
15.2 %
Total assets
112 bn $
Equity
26.5 bn $
Equity ratio
23.6 %
Return on equity
77.8 %
Cash
7.27 bn $
Operating cash flow
16.8 bn $
Free cash flow
–
Shares outstanding
940,745,031

History

Revenue by fiscal year

2016 18.3 bn $
2017 20 bn $
2018 21.5 bn $
2019 22.3 bn $
2020 24.5 bn $
2021 28.3 bn $
2022 28.5 bn $
2023 34.1 bn $
2024 45 bn $
2025 65.2 bn $

Net income by fiscal year

2016 2.74 bn $
2017 -204.1 m $
2018 3.23 bn $
2019 8.32 bn $
2020 6.19 bn $
2021 5.58 bn $
2022 6.24 bn $
2023 5.24 bn $
2024 10.6 bn $
2025 20.6 bn $

Dividend per share

2016 2.05 $
2017 2.12 $
2018 2.33 $
2019 2.68 $
2020 3.07 $
2021 3.53 $
2022 4.07 $
2023 4.69 $
2024 5.40 $
2025 6.23 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202565.2 bn $20.6 bn $22.95 $6.23 $16.8 bn $
202445 bn $10.6 bn $11.71 $5.40 $8.82 bn $
202334.1 bn $5.24 bn $5.80 $4.69 $4.24 bn $
202228.5 bn $6.24 bn $6.90 $4.07 $7.59 bn $
202128.3 bn $5.58 bn $6.12 $3.53 $7.37 bn $
202024.5 bn $6.19 bn $6.79 $3.07 $6.5 bn $
201922.3 bn $8.32 bn $8.89 $2.68 $4.84 bn $
201821.5 bn $3.23 bn $3.13 $2.33 $5.52 bn $
201720 bn $-204.1 m $-0.19 $2.12 $5.62 bn $
201618.3 bn $2.74 bn $2.58 $2.05 $4.85 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)